Williamson Douglas J 4
4 · ACADIA PHARMACEUTICALS INC · Filed Feb 13, 2023
Insider Transaction Report
Form 4
Williamson Douglas J
Executive VP, Research & Dev
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2023-02-10+237,296→ 237,296 totalExercise: $18.97Exp: 2033-02-09→ Common Stock (237,296 underlying) - Award
Restricted Stock Units
2023-02-10+50,655→ 50,655 total→ Common Stock (50,655 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the stock option vest on the first anniversary of February 10, 2023, with the balance vesting in 36 equal monthly installments thereafter, such that the shares subject to the option will be fully vested on the fourth anniversary of such date.
- [F2]Each restricted stock unit is subject to the 2023 Inducement Plan and represents a contingent right to receive one share of Acadia common stock.
- [F3]50% of the shares subject to the restricted stock units vest on the second anniversary of February 10, 2023, with the balance vesting in two equal annual installments thereafter, such that the shares subject to the restricted stock units will be fully vested on the fourth anniversary of such date.